TrialPanorama/TrialPanorama-database huggingface dataset:
Study 32493484 — Predictive Biomarker (PRD): ASAP2 mRNA
Genes: ASAP2; DDEF2; KIAA0400
Study 32496401 — Surrogate Endpoint (SUR): Blood pressure
Study 32496541 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 32496557 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 32497016 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 32497499 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 32500620 — Predictive Biomarker (PRD): TNC mRNA
Genes: TNC; HXB
Study 32500620 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 32500620 — Safety Biomarker (SAF): Interleukin 1
Study 32501454 — Safety Biomarker (SAF): Interleukin 1
Study 32501454 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32501528 — Predictive Biomarker (PRD): MPG mRNA
Genes: MPG; AAG; ANPG; MID1
Study 32501595 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 32502267 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 32503441 — Surrogate Endpoint (SUR): Blood pressure
Study 32503947 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 32503947 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): CCR2 mRNA
Genes: CCR2; CMKBR2
Study 32503950 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 32504369 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study 32504369 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32504550 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 32504550 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 32504550 — Predictive Biomarker (PRD): ERBB3 mRNA
Genes: ERBB3; HER3
Study 32504550 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 32504550 — Predictive Biomarker (PRD): ATG5 mRNA
Genes: ATG5; APG5L; ASP
Study 32504883 — Predictive Biomarker (PRD): Angiopoietin-related protein 4
Genes: ANGPTL4; ARP4; HFARP; PGAR; PP1158; PSEC0166; UNQ171/PRO197
Study 32504883 — Predictive Biomarker (PRD): LPL mRNA
Genes: LPL; LIPD
Study 32504883 — Predictive Biomarker (PRD): ANGPTL8 mRNA
Genes: ANGPTL8; C19orf80; RIFL; UNQ599/PRO1185
Study 32504883 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 32506369 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 32506428 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32506428 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32506428 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 32506428 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 32506695 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32508029 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 32508029 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 32509320 — Predictive Biomarker (PRD): PTS mRNA
Genes: PTS
Study 32511251 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32511251 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 32511534 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 32511695 — Predictive Biomarker (PRD): CPE mRNA
Genes: CPE
Study 32511983 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 32511983 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 32512291 — Surrogate Endpoint (SUR): Blood pressure
Study 32512806 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study 32514450 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 32515349 — Predictive Biomarker (PRD): ACVR1 mRNA
Genes: ACVR1; ACVRLK2
Study 32515349 — Predictive Biomarker (PRD): ACVR1B mRNA
Genes: ACVR1B; ACVRLK4; ALK4
Study 32515349 — Predictive Biomarker (PRD): Mothers against decapentaplegic homolog 2
Genes: SMAD2; MADH2; MADR2
Study 32515679 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 32516377 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study 32518419 — Predictive Biomarker (PRD): JAK1
Genes: JAK1A; JTK3
Study 32518597 — Predictive Biomarker (PRD): Hormone receptor
Study 32518670 — Surrogate Endpoint (SUR): Blood pressure
Study 32518833 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study 32518862 — Surrogate Endpoint (SUR): Total kidney volume
Study 32522679 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 32522679 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study 32522679 — Predictive Biomarker (PRD): PTPRC mRNA
Genes: PTPRC; CD45
Study 32522743 — Predictive Biomarker (PRD): PNP mRNA
Genes: PNP; NP
Study 32522743 — Predictive Biomarker (PRD): LPP mRNA
Genes: LPP
Study 32522846 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study 32522846 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 32523724 — Surrogate Endpoint (SUR): Blood pressure
Study 32524053 — Predictive Biomarker (PRD): FOS mRNA
Genes: FOS; G0S7
Study 32524257 — Surrogate Endpoint (SUR): Forced vital capacity
Study 32524319 — Predictive Biomarker (PRD): PRLR mRNA
Genes: PRLR
Study 32525844 — Predictive Biomarker (PRD): ABO mRNA
Genes: ABO
Study 32526052 — Predictive Biomarker (PRD): GNAS mRNA
Genes: GNAS; GNAS1
Study 32526052 — Predictive Biomarker (PRD); Safety Biomarker (SAF): miR-25-3p
Genes: MIR25
Study 32526052 — Safety Biomarker (SAF): miR-93-5p
Genes: MIR93
Study 32527396 — Surrogate Endpoint (SUR): Blood pressure
Study 32527643 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 32527643 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 32527868 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 32528389 — Safety Biomarker (SAF): SLC6A3
Genes: DAT
Study 32528460 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 32528460 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 32531030 — Predictive Biomarker (PRD): CCS mRNA
Genes: CCS
Study 32531990 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32532225 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 32532226 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 32532991 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 32534242 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 32534583 — Predictive Biomarker (PRD): PLXNA2 mRNA
Genes: PLXNA2; KIAA0463; OCT; PLXN2; UNQ209/PRO235
Study 32536445 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32536445 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32536445 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study 32536445 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study 32536445 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 32536573 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 32536979 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study 32536979 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 32537166 — Predictive Biomarker (PRD): LOX mRNA
Genes: LOX
Study 32539719 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 32539719 — Predictive Biomarker (PRD): CXCR3 mRNA
Genes: CXCR3; GPR9
Study 32539719 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study 32539719 — Predictive Biomarker (PRD): CCR4 mRNA
Genes: CCR4; CMKBR4
Study 32539794 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 32540838 — Surrogate Endpoint (SUR): Blood pressure
Study 32540851 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 32540858 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 32541385 — Safety Biomarker (SAF): Hemoglobin scavenger receptor
Genes: CD163; M130
Study 32542468 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study 32546275 — Predictive Biomarker (PRD): GGT1 mRNA
Genes: GGT1; GGT
Study 32547210 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study 32547210 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 32547424 — Surrogate Endpoint (SUR): Blood pressure
Study 32548285 — Predictive Biomarker (PRD): TNFRSF10C mRNA
Genes: TNFRSF10C; DCR1; LIT; TRAILR3; TRID; UNQ321/PRO366
Study 32552471 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 32553149 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32553333 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study 32554615 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 32556247 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 32556247 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 32556286 — Predictive Biomarker (PRD): GATA2 mRNA
Genes: GATA2
Study 32557834 — Predictive Biomarker (PRD): AIRE mRNA
Genes: AIRE; APECED
Study 32557834 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study 32557834 — Predictive Biomarker (PRD): HDC mRNA
Genes: HDC
Study 32557976 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 32557976 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 32557976 — Predictive Biomarker (PRD): ROS1
Genes: MCF3; ROS; c-ros-1
Study 32559419 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 32559465 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 32561474 — Predictive Biomarker (PRD): NTS mRNA
Genes: NTS
Study 32561664 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 32561908 — Predictive Biomarker (PRD): PNPLA3 mRNA
Genes: PNPLA3; ADPN; C22orf20
Study 32561912 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 32562118 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Plasma DNA
Study 32562118 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 32563721 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32564074 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 32564244 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32564693 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study 32567817 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 32567817 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 32571613 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32572189 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study 32572189 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study 32572560 — Surrogate Endpoint (SUR): Pathological complete response
Study 32573497 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 32573983 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): C-X-C motif chemokine 9
Genes: CXCL9; CMK; MIG; SCYB9
Study 32573983 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-X-C motif chemokine 10
Genes: CXCL10; INP10; SCYB10
Study 32575141 — Predictive Biomarker (PRD): FGF21 mRNA
Genes: FGF21; UNQ3115/PRO10196
Study 32575163 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32575163 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 32576633 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 32577626 — Predictive Biomarker (PRD): DUSP1 mRNA
Genes: DUSP1; CL100; MKP1; PTPN10; VH1
Study 32577878 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 32578220 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 32578220 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study 32578441 — Predictive Biomarker (PRD): RIPK3 mRNA
Genes: RIPK3; RIP3
Study 32578441 — Predictive Biomarker (PRD): COPS8 mRNA
Genes: COPS8; CSN8
Study 32578441 — Predictive Biomarker (PRD): MLKL mRNA
Genes: MLKL
Study 32578441 — Predictive Biomarker (PRD): Apoptosis regulator Bcl-2
Genes: BCL2
Study 32578481 — Surrogate Endpoint (SUR): Blood pressure
Study 32578962 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 32578964 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 32580249 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study 32580757 — Surrogate Endpoint (SUR): Serum uric acid
Study 32580757 — Surrogate Endpoint (SUR): Serum creatinine
Study 32581513 — Predictive Biomarker (PRD): FOS mRNA
Genes: FOS; G0S7
Study 32581767 — Safety Biomarker (SAF): BDNF
Study 32584598 — Predictive Biomarker (PRD): IGFBP7 mRNA
Genes: IGFBP7; MAC25; PSF
Study 32585739 — Safety Biomarker (SAF): Myeloperoxidase
Genes: MPO
Study 32586337 — Surrogate Endpoint (SUR): Blood pressure
Study 32586346 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Growth/differentiation factor 15
Genes: GDF15; MIC1; PDF; PLAB; PTGFB
Study 32586767 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 32586928 — Predictive Biomarker (PRD): LSAMP mRNA
Genes: LSAMP; IGLON3; LAMP
Study 32586937 — Predictive Biomarker (PRD): CCR4 mRNA
Genes: CCR4; CMKBR4
Study 32588127 — Predictive Biomarker (PRD): PNP mRNA
Genes: PNP; NP
Study 32588218 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 32589866 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 32590747 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study 32592467 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study 32592467 — Predictive Biomarker (PRD): ERBB4 mRNA
Genes: ERBB4; HER4
Study 32592467 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 32592467 — Predictive Biomarker (PRD): CNTF mRNA
Genes: CNTF
Study 32593288 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 32593297 — Surrogate Endpoint (SUR): Blood pressure
Study 32593547 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study 32593675 — Surrogate Endpoint (SUR): Blood pressure
Study 32594377 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32594377 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 32595978 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study 32600160 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study 32600160 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 32600160 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study 32600160 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 32601337 — Predictive Biomarker (PRD): CD70 mRNA
Genes: CD70; CD27L; CD27LG; TNFSF7
Study 32601850 — Predictive Biomarker (PRD): EPHB2 mRNA
Genes: EPHB2; DRT; EPHT3; EPTH3; ERK; HEK5; TYRO5
Study 32604962 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study 32604962 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32605575 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 32605575 — Monitoring Biomarker (MOI): Angiopoietin-1
Genes: ANGPT1; KIAA0003
Study 32605575 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Angiopoietin-2
Genes: ANGPT2
Study 32606056 — Predictive Biomarker (PRD): CEP70 mRNA
Genes: CEP70; BITE
Study 32606883 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32606956 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 32607929 — Predictive Biomarker (PRD): SST mRNA
Genes: SST
Study 32608579 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 32608579 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 32608579 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 32611374 — Safety Biomarker (SAF): miR-200a
Genes: MIR200A
Study 32611374 — Safety Biomarker (SAF): miR-200c
Genes: MIR200C
Study 32611608 — Surrogate Endpoint (SUR): Serum uric acid
Study 32611743 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 32611743 — Surrogate Endpoint (SUR): Blood pressure
Study 32612255 — Surrogate Endpoint (SUR): Forced vital capacity
Study 32613082 — Predictive Biomarker (PRD): SLC40A1 mRNA
Genes: SLC40A1; FPN; FPN1; IREG1; SLC11A3; MSTP079
Study 32614391 — Safety Biomarker (SAF): BCHE
Genes: E1
Study 32614963 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study 32615108 — Predictive Biomarker (PRD): PDGFRA mRNA
Genes: PDGFRA; PDGFR2; RHEPDGFRA
Study 32615108 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study 32616555 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 32616555 — Predictive Biomarker (PRD): Microsatellite instability
Study 32617582 — Predictive Biomarker (PRD): DNAJB9 mRNA
Genes: DNAJB9; MDG1; UNQ743/PRO1471
Study 32618572 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 32618884 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 32618884 — Surrogate Endpoint (SUR): Blood pressure
Study 32619077 — Predictive Biomarker (PRD): Hormone receptor
Study 32619077 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 32619115 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 32619740 — Predictive Biomarker (PRD): SCN5A mRNA
Genes: SCN5A
Study 32619740 — Predictive Biomarker (PRD): HEY2 mRNA
Genes: HEY2; BHLHB32; CHF1; GRL; HERP; HERP1; HRT2
Study 32622665 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32622884 — Predictive Biomarker (PRD): FGFR1 mRNA
Genes: FGFR1; BFGFR; CEK; FGFBR; FLG; FLT2; HBGFR
Study 32622884 — Predictive Biomarker (PRD): FGFR2 mRNA
Genes: FGFR2; BEK; KGFR; KSAM
Study 32622884 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study 32623075 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 32623075 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 32623075 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 32623075 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 32623075 — Safety Biomarker (SAF): Serine/threonine-protein kinase STK11
Genes: STK11
Study 32623075 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study 32623075 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 32623316 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study 32624280 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study 32624280 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 32628583 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 32631293 — Predictive Biomarker (PRD): BPI mRNA
Genes: BPI
Study 32631655 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 32631788 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 32632095 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study 32633094 — Surrogate Endpoint (SUR): Blood pressure
Study 32633563 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study 32633563 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 32633861 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 32633861 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 32634122 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 32634610 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 32634610 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 32634611 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 32636632 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 32636632 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 32636632 — Predictive Biomarker (PRD): Hormone receptor
Study 32636771 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study 32638211 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study 32638211 — Predictive Biomarker (PRD): PAX8 mRNA
Genes: PAX8
Study 32639485 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 32639845 — Predictive Biomarker (PRD): NBL1 mRNA
Genes: NBL1; DAN; DAND1
Study 32641032 — Predictive Biomarker (PRD): SLC25A3 mRNA
Genes: SLC25A3; PHC; OK/SW-cl.48
Study 32641418 — Predictive Biomarker (PRD): PLTP mRNA
Genes: PLTP
Study 32641418 — Safety Biomarker (SAF): Uromodulin
Genes: UMOD